LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3536 | 3970 | 0.8906 | 0.8352 |
BT-20 | Lapatinib | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3995 | 3970 | 1.0061 | 1.0091 |
BT-20 | LDN-193189 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 3838 | 3970 | 0.9665 | 0.9496 |
BT-20 | Linifanib | 0.12 | uM | LJP6 | 72 | hr | 1334 | 4249 | 3970 | 1.0701 | 1.1056 |
BT-20 | Linsitinib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 3722 | 3970 | 0.9373 | 0.9056 |
BT-20 | Mitoxantrone | 0.12 | uM | LJP5 | 72 | hr | 1334 | 1148 | 3970 | 0.2893 | -0.0706 |
BT-20 | Mitoxantrone | 0.12 | uM | LJP6 | 72 | hr | 1334 | 1526 | 3970 | 0.3845 | 0.0728 |
BT-20 | MK2206 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3952 | 3970 | 0.9954 | 0.9931 |
BT-20 | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 2945 | 3970 | 0.7418 | 0.6111 |
BT-20 | Nilotinib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4116 | 3970 | 1.0365 | 1.0550 |
BT-20 | Nintedanib | 0.12 | uM | LJP6 | 72 | hr | 1334 | 4041 | 3970 | 1.0177 | 1.0267 |
BT-20 | NU7441 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4100 | 3970 | 1.0325 | 1.0490 |
BT-20 | Dactolisib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 1715 | 3970 | 0.4320 | 0.1444 |
BT-20 | NVP-TAE684 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3094 | 3970 | 0.7792 | 0.6674 |
BT-20 | Palbociclib | 0.12 | uM | LJP6 | 72 | hr | 1334 | 2967 | 3970 | 0.7474 | 0.6194 |
BT-20 | PD0325901 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 3846 | 3970 | 0.9685 | 0.9526 |
BT-20 | PD0325901 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3518 | 3970 | 0.8860 | 0.8283 |
BT-20 | PD173074 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3979 | 3970 | 1.0022 | 1.0033 |
BT-20 | PD184352 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4129 | 3970 | 1.0398 | 1.0600 |
BT-20 | Pelitinib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 3802 | 3970 | 0.9576 | 0.9362 |
BT-20 | PF431396 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 3260 | 3970 | 0.8210 | 0.7303 |
BT-20 | PF477736 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4033 | 3970 | 1.0157 | 1.0237 |
BT-20 | PF562271 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3540 | 3970 | 0.8916 | 0.8367 |
BT-20 | PHA-665752 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4069 | 3970 | 1.0247 | 1.0372 |
BT-20 | PHA-793887 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 2488 | 3970 | 0.6266 | 0.4376 |